# Mozobil

NDC: 0024-5862
Generic name: PLERIXAFOR
Labeler / Manufacturer: Sanofi-Aventis U.S. LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20130901

FDA application: NDA022311

## Active ingredients

- PLERIXAFOR: 24 mg/1.2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0024-5862"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0024-5862
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0ed08d2b-5051-46b2-aa37-1d6275bf9003